<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36787802</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-1095</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of the Royal Society of Medicine</Title><ISOAbbreviation>J R Soc Med</ISOAbbreviation></Journal><ArticleTitle>Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study.</ArticleTitle><Pagination><StartPage>97</StartPage><EndPage>112</EndPage><MedlinePgn>97-112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/01410768231154703</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To determine the prevalence of organ impairment in long COVID patients at 6 and 12 months after initial symptoms and to explore links to clinical presentation.</AbstractText><AbstractText Label="DESIGN">Prospective cohort study.</AbstractText><AbstractText Label="PARTICIPANTS">Individuals.</AbstractText><AbstractText Label="METHODS">In individuals recovered from acute COVID-19, we assessed symptoms, health status, and multi-organ tissue characterisation and function.</AbstractText><AbstractText Label="SETTING">Two non-acute healthcare settings (Oxford and London). Physiological and biochemical investigations were performed at baseline on all individuals, and those with organ impairment were reassessed.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Primary outcome was prevalence of single- and multi-organ impairment at 6 and 12 months post COVID-19.</AbstractText><AbstractText Label="RESULTS">A total of 536 individuals (mean age 45 years, 73% female, 89% white, 32% healthcare workers, 13% acute COVID-19 hospitalisation) completed baseline assessment (median: 6 months post COVID-19); 331 (62%) with organ impairment or incidental findings had follow-up, with reduced symptom burden from baseline (median number of symptoms 10 and 3, at 6 and 12 months, respectively). Extreme breathlessness (38% and 30%), cognitive dysfunction (48% and 38%) and poor health-related quality of life (EQ-5D-5L&#x2009;&lt;&#x2009;0.7; 57% and 45%) were common at 6 and 12 months, and associated with female gender, younger age and single-organ impairment. Single- and multi-organ impairment were present in 69% and 23% at baseline, persisting in 59% and 27% at follow-up, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Organ impairment persisted in 59% of 331 individuals followed up at 1 year post COVID-19, with implications for symptoms, quality of life and longer-term health, signalling the need for prevention and integrated care of long COVID.Trial Registration: ClinicalTrials.gov Identifier: NCT04369807.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dennis</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuthbertson</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, L7 8TX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wootton</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, CH64 7TE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crooks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hull and East Yorkshire Hospitals NHS Foundation Trust, Hull, HU3 2JZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical and Applied Health Research, University of Hull, Hull, HU6 7RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabbay</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Population Health, University of Liverpool, Waterhouse Building, Block B, Brownlow Street, Liverpool, L69 3GF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichert</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouchti</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pansini</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, OX3 0AG, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roca-Fernandez</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomaides-Brears</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hishmeh</LastName><ForeName>Lyth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Long Covid SOS, Faringdon, Oxfordshire, SN7 7EX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attree</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UKDoctors#Longcovid, London, N1 5HZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Rajarshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, OX4 2LL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, NW1 2DA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Barts Health NHS Trust, London, EC1A 7BE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04369807</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Soc Med</MedlineTA><NlmUniqueID>7802879</NlmUniqueID><ISSNLinking>0141-0768</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">organ impairment</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AD, NE, SF, MP, AR-F, HT-B, MK, MR and RB are employees of Perspectum. All other authors have no competing or conflicting interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36787802</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al.. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 2021; 4: e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 2022; 32: e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, O&#x2019;Mahoney L, Ayoubkhani D, Banerjee A, Brightling C, Calvert M, et al.. Understanding and tracking the impact of long COVID in the United Kingdom. Nat Med 2022; 28: 11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021; 594: 259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021; 38: 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale HA, et al.. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Resp Res 2021; 8: e001041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021; 18: e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthberston DJ, Wootton D, et al.. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11: e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Borlotti A, Thomaides-Brears H, Georgiopoulos G, Banerjee R, Robson MD, Fusco DN, et al.. The additive value of cardiovascular magnetic resonance in convalescent COVID-19 patients. Front Cardiovasc Med 2022; 9: 854750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021393</ArticleId><ArticleId IdType="pubmed">35463767</ArticleId></ArticleIdList></Reference><Reference><Citation>Heber SD, Hetterich H, Lorbeer R, Bayerl C, Machann J, Auweter S, et al.. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease. PLoS One 2017; 12: e0177154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5435170</ArticleId><ArticleId IdType="pubmed">28520813</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al.. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, et al.. Characterisation of liver fat in the UK biobank cohort. PLoS One 2017; 12: e0172921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5328634</ArticleId><ArticleId IdType="pubmed">28241076</ArticleId></ArticleIdList></Reference><Reference><Citation>Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci 2006; 1: 9&#x2013;14.</Citation></Reference><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al.. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Shiekh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on Post-COVID symptoms. Pathogens 2022; 11: 269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Luteijn M, Letton W, Robertson J, McDonald S. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One 2021; 16: e0260843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8639065</ArticleId><ArticleId IdType="pubmed">34855874</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 2022; 13: 446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabbay M, Shiels C, Hillage J. Factors associated with the length of fit note-certified sickness episodes in the UK. Occup Environ Med 2015; 72: 467&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">25713158</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R, Ali FM, Nixon SJ, Ingram JR, Salek SM, Finlay AY. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open 2021; 11: e047680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8154981</ArticleId><ArticleId IdType="pubmed">34035105</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open 2022; 12: e050979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8753091</ArticleId><ArticleId IdType="pubmed">35017239</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, Ramakrishnan RK, AlSwaidan N, AlAnazi A, Alhazmi D, et al.. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: a cohort study with 4 months median follow-up. J Infect Public Health 2022; 15: 21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600938</ArticleId><ArticleId IdType="pubmed">34861604</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, et al.. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun 2022; 4: fcab297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL. Long covid-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines 2021; 9: 966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022; 28: 583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray E, Goodfellow H, Bindman J, Blandford A, Bradbury K, Chaudhry T, et al.. Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long COVID-19 (living with COVID-19 recovery): protocol for a mixed-methods study. BMJ Open 2022; 12: e057408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822541</ArticleId><ArticleId IdType="pubmed">35131836</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID &#x2013; metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol 2021; 17: 379&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054121</ArticleId><ArticleId IdType="pubmed">33875855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al.. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021; 372: n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, et al.. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med 2021; 9: 1328&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>